Astrana Health, Inc. (ASTH)
(Delayed Data from NSDQ)
$22.32 USD
+0.44 (2.01%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $22.31 -0.01 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ASTH 22.32 +0.44(2.01%)
Will ASTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ASTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASTH
ASTH vs. CHE: Which Stock Is the Better Value Option?
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
ASTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Astrana Health, KT, Upbound, Noah Holdings and DXP Enterprises
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
ASTH or CHE: Which Is the Better Value Stock Right Now?
Other News for ASTH
Astrana Health (ASTH) Faces Price Target Cut Amid Cost Concerns
Astrana Health price target lowered by $20 at BTIG, here's why
Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference ...
Astrana Health Inc (ASTH) Trading Down 5.35% on Jul 18
Astrana Health Inc (ASTH) Shares Gap Down to $24.7 on Jul 11